Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Early Phase 1
1(25.0%)
4Total
N/A(3)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05570123Not ApplicableCompleted

Effect and Tolerance of Standardized Exclusive Dry Extracts of Curcuma Longa and of Boswellia Serrata Among People With Hand Joint Discomfort and Dysfunction

Role: lead

NCT05089318Completed

Evaluation of Flexofytol® PLUS in Hand Joint Chronic Dyscomfort.

Role: lead

NCT04844658Not ApplicableCompleted

Covid-19, Hospitalized, PatIents, Nasafytol

Role: lead

NCT02909621Not ApplicableCompleted

Evaluation of FLEXOFYTOL® Versus PLACEBO

Role: lead

NCT01909037Early Phase 1Completed

Exploratory Non Comparative Study to Evaluate the Efficacy of Highly Bioavailable Curcumin (Flexofytol) in Patients With Knee Osteoarthritis

Role: lead

All 5 trials loaded